José Trevejo

José Trevejo

Plus aucun poste en cours
54 ans
Health Technology
Commercial Services
Consumer Services

Profil

José Miguel Trevejo was the founder of SmartPharm Therapeutics, Inc. founded in 2017, where he held the title of Director from 2017 to 2019.
He worked as a Medical Director at Genentech, Inc. from 2013 to 2014 and at Vertex Pharmaceuticals (Canada), Inc. from 2010 to 2013.
He was also the Head-Clinical Development & Regulatory Affairs at Visterra, Inc. and the Principal Investigator & Scientist at The Charles Stark Draper Laboratory, Inc. He held the position of Chief Development Officer at Rocket Pharmaceuticals, Inc. and Vice President-Clinical Development at Cyclerion Therapeutics, Inc. He was the Director at Diabetes Hands Foundation.
He will be the Chief Medical Officer at Tarsus Pharmaceuticals, Inc. from 2022 to 2024.
Dr. Trevejo received his undergraduate degree from the University of California, Los Angeles and his doctorate from Weill Cornell Medical College.

Anciens postes connus de José Trevejo

SociétésPosteFin
TARSUS PHARMACEUTICALS, INC. Directeur Technique/Scientifique/R&D 18/01/2024
Directeur Technique/Scientifique/R&D 01/08/2014
Directeur Technique/Scientifique/R&D 01/02/2013
CYCLERION THERAPEUTICS, INC. Corporate Officer/Principal -
ROCKET PHARMACEUTICALS, INC. Corporate Officer/Principal -
Voir l'expérience en détail de José Trevejo

Formation de José Trevejo

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

33

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Health Technology

Health Technology

Consumer Services

Commercial Services

Consumer Services

Commercial Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. José Trevejo
🔇